Fresenius Kabi and the Association for the Advancement of Blood & Biotherapies (AABB) have announced the start of the 19th annual Blood Collectors Week, taking place from September 1 to…
Kiyatec, a leader in functional precision oncology, has announced the publication of a key study in Scientific Reports showcasing the benefits of the 3D Predict Glioma test for high-grade glioma…
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Kazuhiko Fujii) (TOKYO: 4118) has opened its Tomatoh Manufacturing Site in the Tomakomai Tobu Area of Hokkaido, marking its seventh domestic business location and…
Research by THE SAGE GROUP analyzes the prevalence, characteristics, comorbidities, and outcomes of below-the-ankle (BTA) disease, while also exploring the challenges of endovascular revascularization. BTA (below-the-ankle) disease involves atherosclerotic stenoses…
UptimeHealth, in partnership with the College of Biomedical Equipment Technology (CBET), is pleased to announce the Dental Fix Summit 2024. The event will be held from October 3-6, 2024, at…
Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology with its Omnipod® brand, has announced that its Omnipod 5 Automated Insulin Delivery System is now FDA-cleared for adults…
Masimo (NASDAQ: MASI) Signal Extraction Technology® (SET®) pulse oximetry, known for its industry-leading accuracy and clinical validation, continues to set the standard in overcoming the limitations of conventional pulse oximetry.…
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology firm, will ring the Nasdaq opening bell at MarketSite in Times Square, New York on Wednesday, August 28, 2024. “Today, we…
VION Biosciences, a life science platform company specializing in specialty reagents for research, diagnostics, and drug discovery, has announced the acquisition of Echelon Biosciences, a Salt Lake City-based supplier known…
EMulate Therapeutics, Inc. has announced that the Open Journal of Biophysics (OJBIPHY) will publish its manuscript, titled “Magnetic Field Emulations of Small Inhibitor RNA: Effects on Implanted GL261 Tumors in…
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a leading provider of life science research and clinical diagnostics products, has announced the appointment of Jon DiVincenzo as President and Chief Operating…
Amplitude Vascular Systems (AVS), a medical device company specializing in treating severely calcified arterial disease with its Pulse Intravascular Lithotripsy (IVL) platform, has announced a strategic partnership with the Jacobs…